Rigosertib

Onconova reports PhIII flop, putting high-risk MDS program on the chopping block
Endpoints
Mon, 08/24/20 - 10:32 am
Onconova
clinical trials
Rigosertib
myelodysplastic syndrome
More job cuts at Onconova
Bizjournals.com
Wed, 08/31/16 - 08:47 pm
Onconova
layoffs
Rigosertib
Baxter spinoff cancels potential $565M partnership with Bucks County biotech firm
Bizjournals.com
Sat, 03/5/16 - 09:51 am
Baxter
Rigosertib
Onconova
Biotech Stock Roundup: Isis Soars on Positive Data, Onconova Falls
Yahoo/Zacks.com
Wed, 02/26/14 - 10:50 am
Onconova
Isis Pharmaceuticals
Vertex Pharmaceuticals
Kalydeco
ISIS-SMNRx
Rigosertib
Onconova hammered after top drug rigosertib flunks key PhIII study
Fierce Biotech
Thu, 02/20/14 - 05:33 pm
Onconova
Rigosertib
myelodysplastic syndromes
Onconova tanks as its lead candidate flunks PhIII for pancreatic cancer
Fierce Biotech
Wed, 12/18/13 - 12:09 pm
Rigosertib
pancreatic cancer
Onconova
Onconova says data reinforce safety/tolerability profiles of rigosertib
Yahoo/Fly on the Wall
Mon, 12/9/13 - 09:59 am
Onconova
Rigosertib
MDS
Making The Call: Onconova MDS Drug Study Will Succeed
TheStreet.com
Wed, 09/25/13 - 09:21 am
Onconova
MDS
Rigosertib
Celgene
Our BioPharma Catalyst Watch List
Seeking Alpha
Thu, 08/15/13 - 12:09 pm
Astex
Biodel
Insmed
MannKind
Onconova
Afrezza
Dacogen
Arikace
Rigosertib